DailyIQ
|
DailyIQ
|
Last updatedUpdating…

RLAY·Relay Therapeutics, Inc.

$0.00
+0.00 (+0.00%)
High
$0.00
Open
$0.00
Market Cap
-
52W High
—
Low
$0.00
P. Close
-
P/E
-
52W Low
—
Fwd P/E
-
DailyIQ Est.
-
Inst. Ownership
-
Short Interest
-
Days to Cover
-
Technical Score (1D)
99
BULLISH
News Sentiment
-
NO DATA
With a Technical Score of 99, Relay Therapeutics, Inc. (RLAY) sits in the upper tier of the momentum ranking on the 1D timeframe. The bullish bias and BUY signal follow from that rank, and trend strength reads as strong. Sentiment at 50 is diverging from the chart. Because the score is relative, it can stay high while the broader market falls, as long as RLAY holds up better than its peers. $16.68 is the near-term risk reference and $18.59 is the next upside marker if buyers keep pressing. A top momentum rank reflects the prior year of trading, so it changes gradually. Day to day, price levels give the earlier read: a decisive close below $16.68 would say more about near-term risk than the rank itself, while holding above it keeps $18.06 in play.
RLAY|Analyst Targets
Bought (1Y)
0 shares
$0
Sold (1Y)
6,215,230 shares
$120.5M
Patel SanjivPresident and CEO
Sell48,199 shares2026-10-07
Catinazzo ThomasChief Financial Officer
Sell206 shares2026-10-06
Catinazzo ThomasChief Financial Officer
Sell17,511 shares2026-10-06
Patel SanjivPresident and CEO
Sell48,199 shares2026-09-08
Catinazzo ThomasChief Financial Officer
Sell17,717 shares2026-09-08
View full insider trading history →

EPS

EstBeatMiss
$-0.43$-0.42$-0.42$-0.41$-0.40Q3'25Q3'26
QtrEstActual+/−
Q3'26$-0.40 - -
Q3'25$-0.42$-0.43-2.7%

Revenue

EstBeatMiss
$-35,955$41,947.5$119,850$197,752.5$275,655Q3'25Q3'26
QtrEstActual+/−
Q3'26$239,700 - -
Q3'25 - $0 -
Full Earnings BreakdownEstimates, actuals, guidance, and historical context
→

Sector Rotation

Is money rotating into or out of RLAY's sector?

Relay Therapeutics, Inc. sits in the Health Care sector, currently ranked 3rd of 12 GICS sectors by relative-strength rotation score (leading). Within its narrower Biotechnology industry group, RLAY ranks 13th of 15 tracked industries, lagging.

Sector rank
#3 of 12
Sector state
Leading
Sector rotation score
82
Industry rank
#13 of 15

Options Market

What is the options market pricing for RLAY?

CallsPuts

For Relay Therapeutics, Inc.'s nearest expiry (2026-11-20, 33 days out), open interest is put-heavy, a defensive/bearish tilt (put/call ratio of 21.18), with at-the-money implied volatility around 79.0%. The options market is pricing roughly a ±21.5% move by that expiry — a range of about $12.77–$19.79.

Put/call ratio (2026-11-20)
21.18
ATM implied volatility
79.0%
Total open interest
377
Expected move by 2026-11-20
±21.5% ($12.77–$19.79)

Corporate Stakes

Which companies own a stake in RLAY?

$26.4Mheld by GOOGL

Alphabet Inc. reports a stake in Relay Therapeutics, Inc. on SEC Form 13F: 1.4M shares worth $26.4M at the end of Q2 2026, after cutting 154.1K shares that quarter.

Holder
GOOGL
Shares held
1.4M
Value
$26.4M
HolderLast quarterShares% of RLAYValue at filingValue now
Alphabet Inc. GOOGLTrimmed1.4M-$26.4M-

Form 13F lists US-listed shares held at quarter-end and is filed up to 45 days later. Stakes in private companies are not on it.

News & sentiment

What is the news saying about RLAY?

RLAY fell 15.3% over the month to Oct 16.

Daily close and news tone, Sep 16 to Oct 16
$16$18Sep 16Sep 17Sep 18Sep 21Sep 22Sep 23Sep 24Sep 25Sep 28Sep 29Sep 30Oct 1Oct 2Oct 5Oct 6Oct 7Oct 8Oct 9Oct 12Oct 13Oct 14Oct 15Oct 16Sep 16News toneOct 16123
  1. Sep 24 -5.9%
  2. Oct 8 -6.3%same day: Is Relay Therapeutics (RLAY) Cheap After Its Pullback Or Is The Upside Priced In?
  3. Oct 9 +6.3%
Latest stories naming Relay Therapeutics

Technical analysis

How strong is RLAY's momentum right now?

On the daily chart RLAY ranks at the 99th percentile for momentum against 1,057 stocks and ETFs, a bullish reading.

Momentum rank by timeframe0 = weakest, 100 = strongest
See what drives the rankThe inputs behind each timeframe's momentum rank, plus RSI, stochastics, Bollinger Bands and moving averages. Free with an account.

Discover more

How has RLAY done against its peers?

Over the month to Oct 16, RLAY returned −12.9%. Of the 15 related stocks and ETFs, 13 did better, led by MRNA at +51.2%.

Change since Sep 15Through Oct 16
−20%−10%0%+10%+20%+30%+40%+50%+60%+70%Sep 15Oct 16MRNA +51.2%RLAY −12.9%ROIV −15.2%